AssetMark Inc’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.77K Sell
51
-119
-70% -$3.19K ﹤0.01% 3000
2026
Q1
$3.53K Buy
170
+44
+35% +$1.04K ﹤0.01% 2688
2025
Q4
$4.09K Sell
126
-11
-8% -$471 ﹤0.01% 2534
2025
Q3
$7.77K Buy
137
+9
+7% +$461 ﹤0.01% 2203
2025
Q2
$6.38K Buy
128
+124
+3,100% +$5.6K ﹤0.01% 2072
2025
Q1
$118 Sell
4
-1
-20% -$37 ﹤0.01% 2556
2024
Q4
$121 Buy
+5
New +$124 ﹤0.01% 2515
2024
Q2
Sell
-1
Closed -$15 2167
2024
Q1
$15 Buy
+1
New +$11 ﹤0.01% 1891

Other funds holding HIMS

AssetMark Inc's HIMS Position: Q2 2026 in Review

AssetMark Inc reduced its Hims & Hers Health (HIMS) stake by 70% in Q2 2026, selling an estimated $3.19K and leaving 51 shares worth $1.77K. The position accounts for ﹤0.01% of the portfolio, ranked #3000.

AssetMark Inc first reported a position in HIMS in Q1 2024 and has held it in 8 quarters since. The position peaked at $7.77K in Q3 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • AssetMark Inc held 51 shares of Hims & Hers Health worth $1.77K as of Q2 2026.
  • AssetMark Inc sold 119 Hims & Hers Health shares in Q2 2026, an estimated $3.19K.
  • Hims & Hers Health made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #3000 holding.
  • AssetMark Inc first reported a position in Hims & Hers Health in Q1 2024 and has held it in 8 quarters since.
  • AssetMark Inc's Hims & Hers Health position peaked at $7.77K in Q3 2025.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.